$0.856000
0.011.18%
Pre-Market: 5:35 AM EDT
15 minutes delayed
Comments
Loading...
IN8bio
INABNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
IN8bio (NASDAQ:INAB) Stock, Analyst Ratings, Price Targets, Forecasts
IN8bio Inc has a consensus price target of $9.19 based on the ratings of 8 analysts. The high is $19 issued by B. Riley Securities on August 23, 2021. The low is $3 issued by B. Riley Securities on November 11, 2022. The 3 most-recent analyst ratings were released by Jones Trading, HC Wainwright & Co., and HC Wainwright & Co. on June 14, 2024, June 14, 2024, and June 4, 2024, respectively. With an average price target of $10.5 between Jones Trading, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 1126.64% upside for IN8bio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Jones Trading
HC Wainwright & Co.
Laidlaw & Co.
JonesTrading
EF Hutton
1calculated from analyst ratings
Analyst Ratings for IN8bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/14/2024 | Buy Now | 659.35% | Jones Trading | Soumit Roy | $5 → $6.5 | Maintains | Buy | Get Alert |
| 06/14/2024 | Buy Now | 1360.28% | HC Wainwright & Co. | Swayampakula Ramakanth | $12.5 → $12.5 | Reiterates | Buy → Buy | Get Alert |
| 06/04/2024 | Buy Now | 1360.28% | HC Wainwright & Co. | Swayampakula Ramakanth | $12.5 → $12.5 | Reiterates | Buy → Buy | Get Alert |
| 05/13/2024 | Buy Now | 1360.28% | HC Wainwright & Co. | Swayampakula Ramakanth | $14 → $12.5 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | 1535.51% | HC Wainwright & Co. | Swayampakula Ramakanth | → $14 | Reiterates | Buy → Buy | Get Alert |
| 03/18/2024 | Buy Now | 776.17% | Laidlaw & Co. | Yale Jen | → $7.5 | Initiates | → Buy | Get Alert |
| 03/15/2024 | Buy Now | 1535.51% | HC Wainwright & Co. | Swayampakula Ramakanth | → $14 | Reiterates | Buy → Buy | Get Alert |
| 03/13/2024 | Buy Now | 484.11% | JonesTrading | Soumit Roy | → $5 | Initiates | → Buy | Get Alert |
| 11/13/2023 | Buy Now | 1535.51% | HC Wainwright & Co. | Swayampakula Ramakanth | → $14 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | Buy Now | 1535.51% | HC Wainwright & Co. | Swayampakula Ramakanth | → $14 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | Buy Now | 834.58% | EF Hutton | Tony Butler | → $8 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2023 | Buy Now | 1535.51% | HC Wainwright & Co. | Swayampakula Ramakanth | → $14 | Reiterates | Buy → Buy | Get Alert |
| 04/26/2023 | Buy Now | 1535.51% | HC Wainwright & Co. | Swayampakula Ramakanth | → $14 | Reiterates | → Buy | Get Alert |
| 04/24/2023 | Buy Now | 1301.87% | Mizuho | Mara Goldstein | → $12 | Reiterates | → Buy | Get Alert |
| 04/17/2023 | Buy Now | 834.58% | EF Hutton | Tony Butler | → $8 | Maintains | Buy | Get Alert |
| 03/31/2023 | Buy Now | 834.58% | EF Hutton | Tony Butler | → $8 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | Buy Now | 1535.51% | HC Wainwright & Co. | Swayampakula Ramakanth | → $14 | Reiterates | → Buy | Get Alert |
| 03/29/2023 | Buy Now | 834.58% | EF Hutton | Tony Butler | → $8 | Initiates | → Buy | Get Alert |
| 11/11/2022 | Buy Now | 250.47% | B. Riley Securities | Kalpit Patel | $9 → $3 | Downgrade | Buy → Neutral | Get Alert |
| 08/30/2022 | Buy Now | 1535.51% | HC Wainwright & Co. | Swayampakula Ramakanth | → $14 | Initiates | → Buy | Get Alert |
| 01/24/2022 | Buy Now | 951.4% | B. Riley Securities | Kalpit Patel | $19 → $9 | Maintains | Buy | Get Alert |
| 08/24/2021 | Buy Now | 1301.87% | Mizuho | Mara Goldstein | — | Initiates | → Buy | Get Alert |
| 08/23/2021 | Buy Now | 2119.63% | B. Riley Securities | — | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for IN8bio (INAB) stock?
The latest price target for IN8bio (NASDAQ:INAB) was reported by Jones Trading on June 14, 2024. The analyst firm set a price target for $6.50 expecting INAB to rise to within 12 months (a possible 659.35% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for IN8bio (INAB)?
The latest analyst rating for IN8bio (NASDAQ:INAB) was provided by Jones Trading, and IN8bio maintained their buy rating.
When was the last upgrade for IN8bio (INAB)?
There is no last upgrade for IN8bio
When was the last downgrade for IN8bio (INAB)?
The last downgrade for IN8bio Inc happened on November 11, 2022 when B. Riley Securities changed their price target from $9 to $3 for IN8bio Inc.
When is the next analyst rating going to be posted or updated for IN8bio (INAB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of IN8bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for IN8bio was filed on June 14, 2024 so you should expect the next rating to be made available sometime around June 14, 2025.
Is the Analyst Rating IN8bio (INAB) correct?
While ratings are subjective and will change, the latest IN8bio (INAB) rating was a maintained with a price target of $5.00 to $6.50. The current price IN8bio (INAB) is trading at is $0.86, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.